LSX

R&D
Jonah Comstock interview with Dr Tadaaki Taniguchi

LSX 2024 - Dr Tadaaki Taniguchi

At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r

R&D
LSX USA Jonah Comstock and Eloise McLennan Wrapup

Investment outlook: Key takeaways from LSX USA

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies.

R&D
Interview Hakim Yadi and Luba Greenwood at LSX 2024

LSX 2024 - Luba Greenwood and Hakim Yadi

High-profile digital health investor Luba Greenwood recently announced that she’s joined as Chair of the Board at Closed Loop Medicine, a company applying machine learning to precision drug